Does Weight Mngmt Before Pregnancy Reduce Risk of Future CVD? #CardioObstetrics #CardioSky #JACC ACC Summary: www.acc.org/Latest-in-Ca... JACC: www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @accintouch.bsky.social @abraguo.bsky.social @csilvers.bsky.social @anastasiasmihaili.bsky.social
Tiffany Brazile, MD
@tiffanybrazilemd.bsky.social
Cardiology fellow at Inova | Former Postdoc at IEEM and UTSW | IM at PITGIM | Passionate about CV prevention, cardiometabolic health, sex differences in cardiovascular care | former professional dancer.
Role of pre-pregnancy obesity & APOs in mid-life CVD risk explored by Borrowman et al in #JACC. @BrazileTiffany @tiffanybrazilemd.bsky.social @garimasharmamd.bsky.social provide further insights @coconnormd.bsky.social @jaccjournals.bsky.social jacc.org/doi/10.1016/...
📢 Just Published! 🔍 Associations Between Visceral Adipose and Renal Artery Calcification: Findings from the Multi-Ethnic Study of Atherosclerosis. 🔗 Read more: ow.ly/64z150Vu3Bt #CardioSky #MedSky #Cardiology #Atherosclerosis #MedicalResearch #HeartHealth
Don't Miss ASPC’s Imaging MasterClass! 📅 Saturday, April 5 | 10 AM EDT ✅ Free Half-Day Virtual Event Multimodality Cardiovascular Imaging for Prevention: Essential Insights for Clinicians. Course Directors: Alison Bailey, MD, FASPC @a-l-bailey.bsky.social Leandro Slipczuk, MD, PhD ow.ly/C9Si50Vhw53
Congratulations to our founder, @drroxmehran.bsky.social, on becoming Vice-President of @accintouch.bsky.social! 🌟 Dr. Mehran is an incredible advocate for women in cardiology, and we’re proud to have her as a champion empowering women. #CardioSky #ACC25
The reduction in CRP with oral semaglutide is near maximal at the first time point measured, 13 weeks, whereas body weight continues to decline over time, again dissociating weight loss from the anti-inflammatory actions of GLP-1 medicines www.nejm.org/doi/full/10....
As GLP-1 outcome trials are analyzed for correlations between A1c reduction, weight loss, and reduction in primary outcomes, evidence mounts for contributions from non-metabolic actions of GLP-1, including reduction of inflammation. www.science.org/doi/10.1126/...
Enjoyed discussing this complex case at #ACC25 about a recently placed peripheral stent that embolized to the tricuspid valve and required multidisciplinary imaging and management. Fortunately a good outcome for the patient! @ishvnews.bsky.social @accintouch.bsky.social #cardiosky #medsky
An honor to speak at #ACC25 session on grief & pt loss Standing room only tells us we need more of these honest & vulnerable discussions in #MedEd & beyond. Bravo Dr. Amanda Garfinkel! #humanityinmedicine
Honored to present our work at #ACC25 on a novel measure of diastolic function that demonstrates a limitation in early diastolic recoil with progressively decreased diastolic filling time in HFpEF vs controls #heartfailure #cardiosky #medsky @ishvnews.bsky.social @accintouch.bsky.social
#ACC25 Women in Cardiology #ACCWIC Mix ‘N’ Mingle 📅 Sat, March 29 ⏰ 4:30 PM Marriott Marquis Chicago, Great Lakes B Room #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social @erinmichos.bsky.social @mdharringtonc.bsky.social @drjenniferco-vu.bsky.social @drmarthagulati.bsky.social
CKM syndrome disproportionately affects disadvantaged groups and early intervention is critical. Behnam Tehrani, et al discuss emerging RNA treatments in Journal of Cardiovascular Translational Research @coconnormd.bsky.social @garimasharmamd.bsky.social link.springer.com/article/10.1...
RNA Therapies in Cardio-Kidney-Metabolic Syndrome: Advancing Disease Management - Journal of Cardiovascular Translational Research
Cardio-Kidney-Metabolic (CKM) Syndrome involves metabolic, kidney, and cardiovascular dysfunction, disproportionately affecting disadvantaged groups. Its staging (0–4) highlights the importance of ear...
link.springer.com